HF
MREO

HRT Financial’s Mereo BioPharma MREO Stock Holding History

HRT Financial’s Portfolio MREO Stock Details MREO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-34,852
Closed -$71K – 3709
2025
Q3 		$71K Buy
+34,852
New +$64.3K ﹤0.01% 2561
2025
Q2 		– Sell
-15,713
Closed -$35K – 3225
2025
Q1 		$35K Buy
+15,713
New +$44.4K ﹤0.01% 2266
2022
Q3 		– Sell
-39,886
Closed -$44K – 3247
2022
Q2 		$44K Buy
39,886
+23,100
+138% +$17.9K ﹤0.01% 2523
2022
Q1 		$18K Sell
16,786
-3,977
-19% -$5.14K ﹤0.01% 2847
2021
Q4 		$33K Buy
+20,763
New +$41.5K ﹤0.01% 2890

Other funds holding MREO

RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

HRT Financial's MREO Position: Q4 2025 in Review

HRT Financial sold out of Mereo BioPharma (MREO) in Q4 2025, closing a stake of 34,852 shares — an estimated $71K sold.

HRT Financial first reported a position in MREO in Q4 2021 and held it in 5 quarters. The position peaked at $71K in Q3 2025. 70 funds tracked by Wall St. Rank hold MREO as of Q4 2025.

  • HRT Financial reported no remaining Mereo BioPharma position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 34,852 Mereo BioPharma shares in Q4 2025, an estimated $71K.
  • HRT Financial first reported a position in Mereo BioPharma in Q4 2021 and held it in 5 quarters.
  • HRT Financial's Mereo BioPharma position peaked at $71K in Q3 2025.
  • 70 funds tracked by Wall St. Rank held Mereo BioPharma as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.